LOS ANGELES, CA — (Marketwired) — 06/16/15 — , The Official MicroCap News Source, today published an SNNLive Video Interview with Dr. Graham Kelly, Chairman and CEO of Novogen Limited (NASDAQ: NVGN). The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs), according to the company–s website (see here: ). The video interview was recorded at the Marcum MicroCap Conference 2015 in New York City, NY.Click the following link to
Lüneburg, Germany, 10 April 2014 – Novo Nordisk, the world market leader in diabetes care, implemented PAS-X V3.1.5 successfully at their Brazilian site in Montes Claros. With 18 production lines in five process areas, including lines for formulation, filling, inspection, assembling and packaging insulin pens, and two lines for tablet packaging, Montes Claros is one of the company’s largest sites.
By providing "PAS-X Reports & Labels" Content Packages, Werum Software & Systems now offers an even broader range of pre-configured reports and labels along with the associated comprehensive consulting services to its customers.
LOS ANGELES, CA — (Marketwire) — 11/19/12 — (OTCBB: MMRF) today announced that through its wholly owned subsidiary, MMR Life Sciences Group, the Company plans on exploiting its pipeline of biotech assets by facilitating a partnership or other joint venture with a privately held biotech company that has completed its Phase 2 clinical trials and is in the process of beginning Phase 3. The Company has held talks with several privately held biotech companies who are finding it difficult to get
